ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,723.36
      0.08%
      US Tech 100
      19,379.60
      0.30%
      Dow Jones
      42,186.79
      0.15%
      Brent Oil
      74.795
      1.44%
      Bitcoin
      63,633.75
      0.48%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Minerva Neurosciences Inc (NERV)

      7. Minerva Neurosciences Inc (NERV) Financials

      Minerva Neurosciences Inc

      Minerva Neurosciences Inc (NERV)

      NASDAQ
      2.73
      -0.09
      (-3.19%)
      Closed September 23 4:00PM
      Delayed by 15 minutes
      2.73
      0.00
      ( 0.00% )
      Pre Market: 8:09AM
      Delayed by 15 minutes

      Minerva Neurosciences Inc Financial Summary

      The current NERV market cap is 19.09M. The company's latest EPS is USD -4.2905 and P/E is -0.64.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -5.35M-4.52M-6.08M-7.17M-6.68M
      Net Income -6.97M-6.19M-7.82M-9.02M-8.57M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 041.18M000
      Operating Income -75.87M1.85M-45.37M-25.23M-23.12M
      Net Income -72.18M1.94M-49.91M-32.11M-30.01M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 51.6M67.14M63.13M56.9M50.51M
      Total Liabilities 78.21M79.65M83.18M85.36M87.1M
      Total Equity -26.62M-12.51M-20.05M-28.46M-36.59M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 77.5M57.63M77.12M55.09M56.9M
      Total Liabilities 49.72M4.96M69.15M75.11M85.36M
      Total Equity 27.78M52.66M7.98M-20.02M-28.46M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -116k-3.99M-8.79M-14.79M-6.1M
      Investing N/A N/A N/A N/A N/A
      Financing N/A 19.69M19.6M19.6M N/A
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -43.43M-33.82M-24.6M-24.65M-14.79M
      Investing 14.09M24.53M N/A -16k N/A
      Financing 525k13.24M60M N/A 19.6M

      Stats and Ratios

      Market Cap 19.09M
      Price to Earnings Ratio -0.64
      Price to Sales Ratio 0
      Price to Cash Ratio 0.47
      Price to Book Ratio -0.67
      Dividend Yield -

      Share Statistics

      Shares Outstanding 6.99M
      Average Volume (1 week) 8.65k
      Average Volume (1 Month) 10.56k
      52 Week Change -64.36%
      52 Week High 13.49
      52 Week Low 2.26
      Spread (Intraday) 0.12 (4.26%)

      Company Info

      Company Name Minerva Neurosciences Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.minervaneurosciences.com
      Industry pharmaceutical preparations (2834)